TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
SLS

Sellas Life Sciences Group Inc

Healthcare · Biotechnology · —

11.30$ -0.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 96.6% 95.8% 92.8% 94.2% 38.1% 65.7% 60.8% 36.1% 65.3% 57.0% 39.0% 34.5% 49.6% 80.2% 87.2% 84.8% 51.0% 84.0% 96.0%
100.0% 14.5% 95.1% 90.9% 92.2% 36.9% 59.7% 54.3% 29.4% 36.2% 27.5% 6.9% 31.6% 43.8% 76.7% 81.2% 81.8% 40.7% 71.5% 91.8%
100.0% 96.4% 95.1% 90.9% 92.2% 36.9% 64.5% 54.3% 29.4% 36.2% 27.5% 6.9% 31.6% 43.8% 76.7% 81.2% 81.8% 40.7% 71.5% 91.8%
– – – – – – – 4.2% 2.3% 26.4% – – – 1.9% 2.4% – – – – –
– – – – – – 0.0% 0.4% 0.8% -23.7% 0.0% 0.0% – 3.4% 1.0% – – – – –
– – – – – 1.3% 0.1% 0.8% 0.4% 0.4% 0.3% 0.0% – 1.3% 1.9% 2.7% 4.2% – – –
– – – – – 19.0% 10.7% 6.7% 7.5% 7.2% 9.0% 5.7% 11.3% 11.5% 4.2% 7.2% 9.1% 30.8% 9.8% 2.4%
– – – – – 41.5% 23.4% 31.6% 55.6% 26.9% 33.6% 52.5% 50.3% 34.3% 12.4% – – – – –
– 10.9% 13.4% 88.1% 67.5% 67.3% 49.5% 93.3% 54.0% 83.5% 56.5% 93.8% 69.0% 63.3% 39.3% 23.0% 76.8% 228.3% 51.3% 9.5%
– 10.9% 13.4% 87.6% 67.2% 36.2% 29.0% 71.0% 33.8% 69.5% 46.2% 73.3% 35.3% 31.9% 26.8% 18.9% 74.1% 220.9% 48.9% 9.0%
– – 0.3% 0.8% 0.7% 1.7% 0.0% 2.5% 4.9% 5.8% 24.9% 25.0% – 1.3% 0.4% 0.7% 1.8% 7.2% 2.8% 0.7%
– 0.5% 3.8% 10.0% 9.7% 7.0% 3.6% 3.0% 2.8% 1.9% 1.3% 34.9% 22.2% 23.5% 10.1% 8.1% 16.0% 90.7% 18.0% 3.8%
– – – – – – 0.0% 8.8% 5.6% 13.3% 8.6% 7.8% – – – – – – – –
100.0% 89.1% 86.6% 11.9% 32.5% 32.7% 50.5% 6.7% 46.0% 16.5% 43.5% 6.2% 31.0% 36.7% 60.7% 77.0% 23.2% -128.3% 48.7% 90.5%
– -90.5% -244.8% -699.8% -745.6% -217.1% -185.9% -203.3% -267.7% -340.1% -460.3% -161.6% -483.9% -609.0% -256.0% -524.5% -859.0% -3,493.2% -1,276.9% -351.0%
189.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 0.1% 1.5% 15.4% 17.3% 58.6% 92.6% 446.6% 315.0% 139.2%

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?